The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jun. 15, 2021
Filed:
May. 14, 2020
Applicant:
Centivax, Inc., South San Francisco, CA (US);
Inventors:
Jacob Glanville, San Francisco, CA (US);
Shahrad Daraeikia, San Francisco, CA (US);
I-Chieh Wang, San Bruno, CA (US);
Sindy Andrea Liao Chan, San Jose, CA (US);
Jean-Philippe Bürckert, Belmont, CA (US);
Sawsan Youssef, Menlo Park, CA (US);
Assignee:
Centivax, Inc., South San Francisco, CA (US);
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 39/42 (2006.01); C07K 16/28 (2006.01); G01N 33/569 (2006.01); C07K 16/10 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
C07K 16/28 (2013.01); C07K 16/10 (2013.01); G01N 33/56983 (2013.01); A61K 2039/505 (2013.01); C07K 2317/55 (2013.01); C07K 2317/565 (2013.01);
Abstract
This disclosure provides antibodies that are derived from CFR3022 and that can be administered to an individual that is infected with a virus. Antibodies herein can be capable of treating or curing the virus, and which may provide protection against the virus for up to several weeks. Antibodies herein can be used to diagnose a SARS CoV 2 infection.